by Vandana Singh | Feb 17, 2026 | General
Rallybio Corporation (NASDAQ:RLYB) on Tuesday shared results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) clinical trial of RLYB116 for complement-mediated diseases, with its initial focus on immune platelet transfusion refractoriness (PTR)...
by Avi Kapoor | Feb 17, 2026 | General
Celanese Corporation (NYSE:CE) will release earnings results for its fourth quarter, after the closing bell on Tuesday, Feb. 17. Analysts expect the Irving, Texas-based company to report quarterly earnings at 91 cents per share, down from $1.45 per share in the...
by Dylan Berman | Feb 17, 2026 | General
Moderna, Inc. (NASDAQ:MRNA) shares are trading higher Tuesday after the company announced European Commission marketing authorization for its COVID-19 vaccine, mNEXSPIKE. Moderna stock is showing upward movement. What’s pushing MRNA stock higher? European Commission...
by Khyathi Dalal | Feb 17, 2026 | General
Ark Invest CEO Cathie Wood weighed in on Bitcoin’s (CRYPTO: BTC) recent weakness, arguing that the decline reflects algorithmic selling rather than deteriorating fundamentals. Bitcoin vs. Gold: A “Risk-Off” Disconnect In a recent interview, Wood pointed to...
by Vandana Singh | Feb 17, 2026 | General
Polaryx Therapeutics Inc. (NASDAQ:PLYX) shares are up on Tuesday as the company has made significant strides in advancing its clinical programs. The positive movement follows the announcement that Polaryx has selected a contract research organization for its SOTERIA...
Recent Comments